Company performance
Add to research
Current Price
as of May 21, 2025$2.05
P/E Ratio
N/A
Market Cap
$99.03M
Description
Add to research
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Metrics
Add to research
Overview
- HQAustin, TX
- SectorHealth Technology
- IndustryBiotechnology
- TickerSAVA
- Price$2.05-8.48%
Trading Information
- Market cap$99.03M
- Float86.89%
- Average Daily Volume (1m)1,168,861
- Average Daily Volume (3m)1,617,912
- EPS-$1.51
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$23.40M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$24.37M
- EV-$44.93M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.78
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset